Potential Therapeutic Strategy in Chronic Obstructive Pulmonary Disease Using Pioglitazone-Augmented Wharton's Jelly-Derived Mesenchymal Stem Cells

BACKGROUND: A recent study reported that mesenchymal stem cells possess potential cellular therapeutic properties for treating patients with chronic obstructive pulmonary disease, which is characterized by emphysema. We examined the potential therapeutic effect of Wharton's Jelly-derived mesenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jin-Soo, Kim, Hyun Kuk, Kang, Eun-Young, Cho, RyeonJin, Oh, Yeon-Mok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435932/
https://www.ncbi.nlm.nih.gov/pubmed/30302955
http://dx.doi.org/10.4046/trd.2018.0044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435932/
https://www.ncbi.nlm.nih.gov/pubmed/30302955
http://dx.doi.org/10.4046/trd.2018.0044

Ejemplares similares